cnbc semaglutide India's obesity and diabetes drug market is on the verge of taking off. Semaglutide, the molecule behind Ozempic and Wegovy will go off patent this Saturday paving the way for low-cost generic drugs Obesity Drugs Set To Take

What is the recommended conversion dose from semaglutide (glucagon-like peptide-1 (GLP-1) receptor agonist) 2mg per week to tirzepatide (dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist)?

It's very exciting to have, especially since it's more of a noninvasive strategy compared to bariatric surgery, and a lot more patients will be open to it.

We use regular metabolic blood work to track your internal health markers and identify potential stressors early

Maximizing absorption from every dose Beyond avoiding mistakes, several evidence-based strategies can improve how much active compound reaches your bloodstream from each dose